West Pharmaceutical Services
West Pharmaceutical Services, our mission is to develop and apply proprietary technologies that improve the safety and effectiveness.
Launch date
Employees
Market cap
CAD29.4b
Enterprise valuation
CAD29.2b (Public information from Sep 2024)
Share price
$311.20001 WST
Bristol Township Pennsylvania (HQ)
Financials
Estimates*
USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 2.1b | 2.8b | 2.9b | 2.9b | 2.9b | 3.1b | 3.4b |
% growth | 17 % | 32 % | 2 % | 2 % | (3 %) | 8 % | 9 % |
EBITDA | 517m | 878m | 855m | 876m | 702m | 861m | 982m |
% EBITDA margin | 24 % | 31 % | 30 % | 30 % | 24 % | 28 % | 29 % |
Profit | 346m | 662m | 586m | 593m | 484m | 599m | 703m |
% profit margin | 16 % | 23 % | 20 % | 20 % | 17 % | 19 % | 21 % |
EV / revenue | 9.8x | 12.3x | 5.8x | 8.6x | 7.7x | 7.1x | 6.4x |
EV / EBITDA | 40.5x | 39.5x | 19.6x | 29.0x | 31.6x | 25.5x | 22.1x |
R&D budget | 46.9m | 52.8m | 58.5m | 68.4m | - | - | - |
R&D % of revenue | 2 % | 2 % | 2 % | 2 % | - | - | - |
Source: Dealroom estimates
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
* | $520k | Post IPO Equity | |
Total Funding | - |
Related Content
Recent News about West Pharmaceutical Services
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by West Pharmaceutical Services
EditACQUISITION by Viatris May 2016